Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs CHANDRA BHAGAT PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON CHANDRA BHAGAT PHARMA BIOCON /
CHANDRA BHAGAT PHARMA
 
P/E (TTM) x 19.9 - - View Chart
P/BV x 1.8 2.8 65.1% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 BIOCON    CHANDRA BHAGAT PHARMA
EQUITY SHARE DATA
    BIOCON
Mar-23
CHANDRA BHAGAT PHARMA
Mar-23
BIOCON /
CHANDRA BHAGAT PHARMA
5-Yr Chart
Click to enlarge
High Rs388136 285.1%   
Low Rs19283 230.8%   
Sales per share (Unadj.) Rs93.1158.5 58.7%  
Earnings per share (Unadj.) Rs5.41.2 446.8%  
Cash flow per share (Unadj.) Rs14.61.3 1,086.9%  
Dividends per share (Unadj.) Rs1.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs146.536.4 402.6%  
Shares outstanding (eoy) m1,200.607.55 15,902.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.10.7 450.9%   
Avg P/E ratio x54.191.2 59.3%  
P/CF ratio (eoy) x19.881.3 24.4%  
Price / Book Value ratio x2.03.0 65.8%  
Dividend payout %28.00-   
Avg Mkt Cap Rs m347,814826 42,098.7%   
No. of employees `000NANA-   
Total wages/salary Rs m21,81013 164,977.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m111,7421,197 9,337.4%  
Other income Rs m7,6813 262,150.2%   
Total revenues Rs m119,4231,200 9,954.8%   
Gross profit Rs m16,61132 52,268.7%  
Depreciation Rs m11,1311 1,002,792.8%   
Interest Rs m4,19022 19,062.8%   
Profit before tax Rs m8,97112 77,203.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,5413 98,871.6%   
Profit after tax Rs m6,4309 71,049.7%  
Gross profit margin %14.92.7 559.8%  
Effective tax rate %28.322.1 128.3%   
Net profit margin %5.80.8 760.6%  
BALANCE SHEET DATA
Current assets Rs m123,340589 20,942.0%   
Current liabilities Rs m85,107269 31,581.9%   
Net working cap to sales %34.226.7 128.2%  
Current ratio x1.42.2 66.3%  
Inventory Days Days1290 38,488.1%  
Debtors Days Days117250 46.7%  
Net fixed assets Rs m394,0787 5,413,159.3%   
Share capital Rs m6,00375 7,956.3%   
"Free" reserves Rs m169,926199 85,244.3%   
Net worth Rs m175,929275 64,023.1%   
Long term debt Rs m152,90539 389,269.3%   
Total assets Rs m517,418606 85,406.5%  
Interest coverage x3.11.5 205.5%   
Debt to equity ratio x0.90.1 608.0%  
Sales to assets ratio x0.22.0 10.9%   
Return on assets %2.15.1 40.1%  
Return on equity %3.73.3 110.9%  
Return on capital %4.010.7 37.4%  
Exports to sales %3.148.1 6.4%   
Imports to sales %6.00-   
Exports (fob) Rs m3,467576 602.1%   
Imports (cif) Rs m6,654NA-   
Fx inflow Rs m3,467576 602.1%   
Fx outflow Rs m6,6547 95,466.3%   
Net fx Rs m-3,187569 -560.3%   
CASH FLOW
From Operations Rs m18,52553 35,191.9%  
From Investments Rs m-142,818-1 24,206,440.7%  
From Financial Activity Rs m130,487-44 -293,427.0%  
Net Cashflow Rs m6,4118 84,577.8%  

Share Holding

Indian Promoters % 40.4 68.7 58.8%  
Foreign collaborators % 20.3 0.0 -  
Indian inst/Mut Fund % 21.1 2.2 948.6%  
FIIs % 6.6 1.3 492.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 31.3 125.7%  
Shareholders   434,339 134 324,133.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Biocon vs CHANDRA BHAGAT PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Biocon vs CHANDRA BHAGAT PHARMA Share Price Performance

Period Biocon CHANDRA BHAGAT PHARMA S&P BSE HEALTHCARE
1-Day 1.60% -11.13% -1.23%
1-Month 6.73% -3.66% 1.07%
1-Year 15.17% -10.51% 50.86%
3-Year CAGR -13.04% 29.48% 14.38%
5-Year CAGR -2.77% 14.54% 19.01%

* Compound Annual Growth Rate

Here are more details on the Biocon share price and the CHANDRA BHAGAT PHARMA share price.

Moving on to shareholding structures...

The promoters of Biocon hold a 60.6% stake in the company. In case of CHANDRA BHAGAT PHARMA the stake stands at 68.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of CHANDRA BHAGAT PHARMA.

Finally, a word on dividends...

In the most recent financial year, Biocon paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 28.0%.

CHANDRA BHAGAT PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Biocon, and the dividend history of CHANDRA BHAGAT PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Falls 1,000 Points from Day's High, Slides for 4th Day | Nifty Below 22,100 | Infosys, Bajaj Auto Surge Ahead of Q3 Results Sensex Today Falls 1,000 Points from Day's High, Slides for 4th Day | Nifty Below 22,100 | Infosys, Bajaj Auto Surge Ahead of Q3 Results(Closing)

It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.